Breaking News
2 hours ago
Vaibhavi M.
Kiora names leading retina expert Dr. Taiji Sakamoto to its Scientific Advisory Board as it advances non-steroidal retinal therapies.
Vaibhavi M.
Eyestem receives CDSCO approval to begin Phase 2 trials of Eyecyte-RPE for geographic atrophy in dry age-related macular degeneration.
Team Pharma Now
GRI Bio expands its IP portfolio with a newly issued US patent supporting its NKT cell immunomodulation platform.
Simantini Singh Deo
Cogent’s bezuclastinib–sunitinib combo receives FDA Breakthrough designation for treating advanced GIST after imatinib.
Simantini Singh Deo